The emergence of the theranostic sees drugs firms looking for partners in diagnostics - Update
This article was originally published in Clinica
A new breed of product is emerging - nestled between diagnostics and therapeutics is the "theranostic", or maybe even the "therametric". Defined as a test that influences therapeutic decisions, it might identify candidates for drug therapy or could be used to provide feedback on how well a drug is working. Zosia Chustecka looks at developments in this nascent field.